Physician profile
Gagan Mathur
NPI 1386999175
$11,998.23
in general payments reported to CMS, 2019-2025
12 companies · $282 in 2025
The $282 reported for 2025 was more than what a typical Blood Banking & Transfusion Medicine provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2022: $10K · 2023: $799 · 2024: $305 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,386.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmacosmos Therapeutics INC. | $10,126.92 | 2022 | |
| Hemosonics LLC | $733.50 | 2023-2025 | Quantra Qplus System, Qunatra Qplus System |
| Genzyme Corporation | $219.08 | 2023 | |
| Celgene Corporation | $177.46 | 2024 | Reblozyl |
| Werfen USA LLC | $175.07 | 2022-2023 | |
| Baxter Healthcare | $123.73 | 2019 | |
| Karyopharm Therapeutics INC. | $119.76 | 2023 | Xpovio |
| Shionogi INC | $119.50 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $112.59 | 2019 | |
| Octapharma USA, INC. | $41.60 | 2022 | |
| Grifols Shared Services North America, INC. | $28.11 | 2025 | |
| Pfizer INC. | $20.91 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gagan Mathur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.